Friday, 16 October 2026European Markets

RANA GRUBER, HOLLAND COLOURS, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Basic Materials Sector.

Loading stream...

(VIANEWS) - RANA GRUBER (RANA.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Basic Materials sector.

Financial Asset Price Forward Dividend Yield Return on Equity
RANA GRUBER (RANA.OL) kr79.70 14.27% 78.57%
HOLLAND COLOURS (HOLCO.AS) €88.00 3.92% 6.75%
AKZO NOBEL (AKZA.AS) €74.70 2.74% 9.12%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. RANA GRUBER (RANA.OL)

14.27% Forward Dividend Yield and 78.57% Return On Equity

Rana Gruber ASA engages in the mining, processing, and sale of iron ore concentrate. The company excavates, processes, and sells iron oxide in the form of hematite, magnetite, and iron oxide pigments. It also produces magnetite iron oxide concentrates. The company offers its products under the Colorana brands. It exports its products worldwide. Rana Gruber ASA was founded in 1937 and is headquartered in Mo i Rana, Norway.

Earnings Per Share

As for profitability, RANA GRUBER has a trailing twelve months EPS of kr15.39.

PE Ratio

RANA GRUBER has a trailing twelve months price to earnings ratio of 5.18. Meaning, the purchaser of the share is investing kr5.18 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 78.57%.

More news about RANA GRUBER.

2. HOLLAND COLOURS (HOLCO.AS)

3.92% Forward Dividend Yield and 6.75% Return On Equity

Holland Colours N.V., together with its subsidiaries, manufactures, distributes, and sells color concentrates in Europe, the Middle East, India, Africa, the Americas, and Asia. The company offers colorants for the building and construction industry, including profiles, pipes, tubing and fittings, siding and cladding, decking, fencing, window blinds, and insulation, as well as solutions for a range of polymers. It also provides colorants for packaging applications comprising water, carbonated soft drinks, fruit juices, dairy, beer, wine, detergents, pharmaceutical, and personal care products. In addition, the company offers coatings, sealants, or adhesives; and colorants for other markets, such as shopping bags, polybags, mulch films, OPP tapes, PU flexible foams, synthetic leather, fiber glass and buttons, paving blocks, artificial stones, cast PMMA, PP non-woven and spunbond, coatings, flexible PVCs, prosthetics, glass fiber reinforced nylon, and silicone rubber and elastomers. It sells its products through a network of agents and distributors. The company was founded in 1979 and is headquartered in Apeldoorn, the Netherlands. Holland Colours N.V. is a subsidiary of Holland Pigments BV.

Earnings Per Share

As for profitability, HOLLAND COLOURS has a trailing twelve months EPS of €4.68.

PE Ratio

HOLLAND COLOURS has a trailing twelve months price to earnings ratio of 18.8. Meaning, the purchaser of the share is investing €18.8 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.75%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Jul 17, 2023, the estimated forward annual dividend rate is 3.41 and the estimated forward annual dividend yield is 3.92%.

Volatility

HOLLAND COLOURS's last week, last month's, and last quarter's current intraday variation average was 1.72%, 0.19%, and 2.08%.

HOLLAND COLOURS's highest amplitude of average volatility was 3.29% (last week), 2.37% (last month), and 2.08% (last quarter).

More news about HOLLAND COLOURS.

3. AKZO NOBEL (AKZA.AS)

2.74% Forward Dividend Yield and 9.12% Return On Equity

Akzo Nobel N.V. engages in the production and sale of paints and coatings worldwide. It offers decorative paints, including paints, lacquers, and varnishes; and a range of mixing machines and color concepts for the building and renovation industry, as well as specialty coatings. The company also provides performance coatings that protect and enhance ships, cars, aircraft, yachts, architectural components, consumer goods, and oil and gas facilities. It offers its products primarily under AkzoNobel, Alabastine, Alba, Andercol, Apla, Armstead Trade, Astral, AwlGrip, Dulux, Bruguer, Cetabever, Cetol, Chemcraft, Colourland Paints, Coral, Cromadex, Cuprinol, Dynacoat, Flexa, Glitsa, Grip-Gard, Zweihorn, Xylazel, Xyladecor, Wanda, Vpowdertech, Vivechrom, U-tech, Trimetal, Titanlux, Taubmans, Sparlack, Sikkens, Savana, and Salcomix, as well as Sadolin, Resicoat, Relest, Procolor, Polyfilla, Polycell, Pinotex, Pintuco, Oxirite, Nordsjo, Molto, Modern Classikk, Maxilite, Mauvilac, Mason CT, Marshall, Laxol, Levis, Lesonal, Interpon, International, Interlux, Innenweis, Inca, Herbol, and Hammerite brands. The company was formerly known as Akzo NV and changed its name to Akzo Nobel N.V. in 1994. Akzo Nobel N.V. was founded in 1646 and is headquartered in Amsterdam, the Netherlands.

Earnings Per Share

As for profitability, AKZO NOBEL has a trailing twelve months EPS of €2.36.

PE Ratio

AKZO NOBEL has a trailing twelve months price to earnings ratio of 31.65. Meaning, the purchaser of the share is investing €31.65 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.12%.

More news about AKZO NOBEL.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com